CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Ainos Inc   (AIMD)
Other Ticker:  
 
 

AIMD's Capital Expenditures Growth by Quarter and Year

Ainos Inc 's Capital Expenditures results by quarter and year




AIMD Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.00 0.00 0.14 0.01
III Quarter September 0.11 0.25 0.00 0.00
II Quarter June 0.00 0.49 0.00 0.00
I Quarter March 0.07 -0.07 0.00 0.00
FY   0.18 0.67 0.14 0.01



AIMD Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Ainos Inc in the fourth quarter 2023 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the fourth quarter 2023, Ainos Inc achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Ainos Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the fourth quarter 2023.


AIMD Capital Expenditures ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - 1300 % 0 %
III Quarter September -56 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -73.13 % 378.57 % 1300 % 0 %

Financial Statements
Ainos Inc 's fourth quarter 2023 Capital Expenditures $ 0.00 millions AIMD's Income Statement
Ainos Inc 's fourth quarter 2022 Capital Expenditures $ 0.00 millions Quarterly AIMD's Income Statement
New: More AIMD's historic Capital Expenditures Growth >>


AIMD Capital Expenditures (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - -48.98 % - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -73.13 % 378.57 % 1300 % 0 %


Suppliers by AIMD Divisions >> Back to AIMD Growth rate Comparisons >>


Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Ainos Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AIMD's IV. Quarter Q/Q Capital Expenditures Comment
IV. Quarter 2023 results of 0.00 millions by Ainos Inc come out even worse if you take a look at 0.11 millions a quarter before.

Within Major Pharmaceutical Preparations industry Ainos Inc achieved highest sequential Capital Expenditures growth. While Ainos Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AIMD's IV. Quarter Q/Q Capital Expenditures Comment
Recent Capital Expenditures of 0.00 millions by Ainos Inc appear even more unfavourable compare to the 0.11 millions Capital Expenditures in the third quarter.

Within Major Pharmaceutical Preparations industry Ainos Inc achieved highest sequential Capital Expenditures growth. While Ainos Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Ainos Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #

New: More AIMD's historic Capital Expenditures Growth >>



Cumulative Capital Expenditures growth Comment
In the Dec 31 2023 period, Ainos Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Ainos Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Dec 31 2023 period, Ainos Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Ainos Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
AIMD's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for AIMD's Competitors
Capital Expenditures Growth for Ainos Inc 's Suppliers
Capital Expenditures Growth for AIMD's Customers

You may also want to know
AIMD's Annual Growth Rates AIMD's Profitability Ratios AIMD's Asset Turnover Ratio AIMD's Dividend Growth
AIMD's Roe AIMD's Valuation Ratios AIMD's Financial Strength Ratios AIMD's Dividend Payout Ratio
AIMD's Roa AIMD's Inventory Turnover Ratio AIMD's Growth Rates AIMD's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2023
Sunshine Biopharma Inc -0.43%$ -0.431 millions
Infusystem Holdings Inc -0.73%$ -0.730 millions
Stereotaxis Inc -0.81%$ -0.813 millions
Icon Plc-1.03%$ -1.033 millions
Alpine Immune Sciences Inc -1.72%$ -1.724 millions
Argenx se-2.99%$ -2.987 millions
Abbvie inc -3.76%$ -3.756 millions
Vanda Pharmaceuticals Inc -3.80%$ -3.802 millions
Warby Parker Inc -4.52%$ -4.516 millions
Bristol myers Squibb Company-4.62%$ -4.624 millions
Baxter International Inc -5.00%$ -5.000 millions
Progyny Inc -5.55%$ -5.548 millions
Precipio inc -5.77%$ -5.769 millions
Koru Medical Systems Inc-6.92%$ -6.916 millions
Ufp Technologies Inc -7.02%$ -7.018 millions
Bio rad Laboratories Inc -7.27%$ -7.272 millions
Endo International Plc-8.13%$ -8.130 millions
Eterna Therapeutics Inc -9.52%$ -9.524 millions
Sotera Health Company-9.63%$ -9.633 millions
Hutchmed china Limited-11.05%$ -11.052 millions
Biolinerx Ltd -11.45%$ -11.450 millions
Petvivo Holdings Inc-11.46%$ -11.461 millions
Novartis Ag-11.52%$ -11.519 millions
Charles River Laboratories International inc -12.02%$ -12.020 millions
Surgery Partners Inc -12.78%$ -12.775 millions
Xbiotech Inc -12.88%$ -12.879 millions
Cardiol Therapeutics inc -13.92%$ -13.917 millions
Conmed Corporation-14.46%$ -14.464 millions
Msa Safety Incorporated-14.60%$ -14.601 millions
Teva Pharmaceutical Industries Limited-16.20%$ -16.197 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com